Table 3.
LC3 and P62 expression levels in peripheral blood lymphocytes of normal children (C), pre-treatment SEL (SLE), traditional treatment at the end of 6 months (A), sirolimus treatment at the end of 6 months (B) ( ± s).
| Group | n | LC3 relative expression | p62 relative expression |
|---|---|---|---|
| Normal group | 15 | 0.3686 686.0832 | 0.6005 005.0890 |
| SLE | 30 | 0.5175 175.0721 | 0.4965 965.0730 |
| Traditional treatment group | 28 | 0.5097 097.0911* | 0.4942 942.0688* |
| Sirolimus group | 28 | 0.6485 485.1314*# | 0.4028 028.0765*# |
Compared with SLE before treatment, *P < 0.05; Compared with the traditional treatment group, #P < 0.05.